Actively Recruiting

Phase Not Applicable
Age: 18Years - 60Years
All Genders
NCT06653803

Rhomboid Intercostal Block Versus Retrolaminar Block for Postoperative Analgesia After Thoracoscopic Sympathectomy

Led by Damanhour Teaching Hospital · Updated on 2025-08-21

60

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Background: Although thoracoscopic sympathectomy is made via small incisions, it is associated with severe postoperative pain. Both Rhomboid intercostal block (RIB) and Retrolaminar block (RLB) are recent techniques used for pain control after such procedures Objectives: To compare the effectiveness of RIB and RLB in providing postoperative analgesia after thoracoscopic sympathectomy in adult patients and their impact on the patient's outcomes. Patients and Methods: This prospective, randomized (1:1), double-blind clinical trial; will be carried out on 60 patients scheduled for elective thoracoscopic sympathectomy under general anesthesia at our hospital. Patients will be randomly allocated into two equal groups (30 patients each) and will receive: in group A; general anesthesia with intraoperative ipsilateral ultrasound-guided RIB, whereas in group B; general anesthesia with intraoperative ipsilateral ultrasound-guided RLB.

CONDITIONS

Official Title

Rhomboid Intercostal Block Versus Retrolaminar Block for Postoperative Analgesia After Thoracoscopic Sympathectomy

Who Can Participate

Age: 18Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • American Society of Anesthesiologists (ASA) physical status  II
  • Age from 18 to 60 years
  • Body Mass Index (BMI) < 35 kg/m8
Not Eligible

You will not qualify if you...

  • American Society of Anesthesiologists (ASA) physical status > II
  • Age < 18 years or > 60 years
  • Body Mass Index (BMI)  35
  • Local infection at the puncture site
  • Altered mental status
  • Pregnant women
  • Allergy to study drugs
  • Chronic pain
  • Coagulation abnormalities or on anticoagulants
  • Severe hepatic or kidney disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Damanhour Teaching Hospital

Damanhūr, El-Beheira, Egypt

Actively Recruiting

Loading map...

Research Team

A

Ahmed M Shaat, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here